Truglifmet 12.5/500 mg Tablet (14 Tablets)

Composition:

• Active Ingredients:
  • Empagliflozin: 12.5 mg
  • Metformin: 500 mg

Indications:

• Used for the management of type 2 diabetes mellitus, often in combination with diet and exercise.

Mechanism of Action:

• Empagliflozin: A sodium-glucose co-transporter 2 (SGLT2) inhibitor that works by preventing glucose reabsorption in the kidneys, promoting glucose excretion in urine.
• Metformin: A biguanide that improves insulin sensitivity, reduces hepatic glucose production, and enhances peripheral glucose uptake and utilization.

Dosage:

• Common starting dose may be 1 tablet taken once daily, but adjustments should be based on individual patient needs and response.
• Always follow the prescribing physician’s instructions.

Side Effects:

• Common Side Effects: Nausea, diarrhea, abdominal discomfort, increased urination.
• Serious Side Effects: Risk of lactic acidosis (rare but serious), urinary tract infections, and dehydration.

Contraindications:

• Not suitable for patients with severe renal impairment, diabetic ketoacidosis, or known hypersensitivity to either active ingredient.

Storage:

• Store at room temperature, away from direct sunlight and moisture.

Precautions:

• Regular monitoring of kidney function is recommended.
• Patients should be advised on signs of lactic acidosis and urinary infections.

Patient Counseling:

• Encourage a healthy diet and regular exercise.
• Advise on the importance of adherence to the prescribed regimen.

For detailed instructions and personalized advice, always consult with a healthcare professional.